Grifols Company Profile

Aggregated data from the web about Grifols

Company Name	Grifols
Website	https://www.grifols.com
Snippet	Grifols is a leading global healthcare company that develops medicines derived from plasma and other innovative biotech solutions to enable millions of patients around the world to lead more rewarding lives.
ISIN	ES0171996012
Type	Sociedad Anónima
Founded	1940
Revenue	€3.934 billion (2015), €3.355 billion (2014) [1]: 8
Website	www.grifols.com
Industry	Pharmaceuticals, chemicals
Products	Plasma derivatives, in vitro diagnostic products, non-biological products for laboratories and hospitals
Traded as	BMAD: GRF, Nasdaq: GRFS
Key people	Víctor Grífols (Chairman and CEO)
Net income	€532.1 million (2015), €470.3 million (2014)[1]: 8
Headquarters	Barcelona, Spain
Total assets	€9.601 billion (2015), €8,449.7 million (2014)[1]: 6
Total equity	€3.3014 billion (2015), €2,662.9 million (2014)[1]: 7
Operating income	€970.4 million (2015), €857.7 million (2014) [1]: 8
Number of employees	21,500 (2019, average) [1]: 64

Grifols is part of the Spain company list

Grifols is part of the Chemicals company list

Grifols is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.